- Home
- NTZ vs FBRX Comparison
NTZ vs FBRX Comparison
Compare NTZ & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- FBRX
- Stock Information
- Founded
- NTZ 1959
- FBRX N/A
- Country
- NTZ Italy
- FBRX United States
- Employees
- NTZ N/A
- FBRX N/A
- Industry
- NTZ Home Furnishings
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- FBRX Health Care
- Exchange
- NTZ Nasdaq
- FBRX Nasdaq
- Market Cap
- NTZ 49.5M
- FBRX 44.8M
- IPO Year
- NTZ 1993
- FBRX N/A
- Fundamental
- Price
- NTZ $3.25
- FBRX $8.49
- Analyst Decision
- NTZ
- FBRX Strong Buy
- Analyst Count
- NTZ 0
- FBRX 3
- Target Price
- NTZ N/A
- FBRX $80.50
- AVG Volume (30 Days)
- NTZ 4.0K
- FBRX 24.2K
- Earning Date
- NTZ 06-20-2025
- FBRX 05-15-2025
- Dividend Yield
- NTZ N/A
- FBRX N/A
- EPS Growth
- NTZ N/A
- FBRX N/A
- EPS
- NTZ N/A
- FBRX N/A
- Revenue
- NTZ $330,051,765.00
- FBRX N/A
- Revenue This Year
- NTZ N/A
- FBRX N/A
- Revenue Next Year
- NTZ N/A
- FBRX N/A
- P/E Ratio
- NTZ N/A
- FBRX N/A
- Revenue Growth
- NTZ N/A
- FBRX N/A
- 52 Week Low
- NTZ $3.07
- FBRX $4.11
- 52 Week High
- NTZ $6.27
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- NTZ 33.17
- FBRX 63.07
- Support Level
- NTZ $3.27
- FBRX $7.00
- Resistance Level
- NTZ $3.75
- FBRX $8.75
- Average True Range (ATR)
- NTZ 0.19
- FBRX 0.69
- MACD
- NTZ -0.03
- FBRX 0.15
- Stochastic Oscillator
- NTZ 9.47
- FBRX 90.08
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).